Contribution of astrocytes to beneficial responses of lovastatin in fragile X syndrome

Project Details

StatusFinished
Effective start/end date01/06/201931/05/2020

Funding

  • Fraxa Research Foundation: €40,500.00
  • Arvo ja Lea Ylppö Säätiö: €6,000.00
  • Fraxa Research Foundation: €17,517.74

Fields of Science

  • 3111 Biomedicine
  • autism
  • fragile X syndrome
  • Stem cells
  • 3112 Neurosciences
  • astrocytes
  • neurologiset poikkeamat
  • intellectual disability